Search


 
Results 1 - 9 of about 9 for "FDA update".

Sodium polystyrene sulfonate should be taken separately from ...

The FDA's recommendation follows a study finding that sodium polystyrene sulfonate also binds to many common oral medications, which decreases ...

Weight-loss devices linked to patient deaths | ACP ...

In a letter to clinicians, the FDA noted five reports of unanticipated deaths that occurred from 2016 to the present in patients treated with liquid-filled intragastric ...

Regorafenib now FDA-approved to treat hepatocellular ...

Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.

IBS-D drug should not be prescribed to patients without ...

The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.

New drug approved for carcinoid syndrome diarrhea | ACP ...

The drug reduces the frequency of diarrhea by inhibiting the production of serotonin by carcinoid tumors.

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.

Duodenoscopes recalled | ACP Gastroenterology Monthly

The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...

New HCV drug combo approved | ACP Gastroenterology ...

The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.